Real-World Outcomes of Treatment With Insulin Glargine 300 u/mL Versus Standard-Of-Care in People With Uncontrolled Type 2 Diabetes Mellitus

Current Medical Research and Opinion - United Kingdom
doi 10.1080/03007995.2019.1708287